• Facebook
• Twitter
• LinkedIn

• HOME
• ABOUT US
  • Market
  • History
  • CEO & MD Message
  • Mission, Vision & Goal
  • Corporate Objective
  • Our Ethics
  • Our Strengths
• Company
  • Executive Team
  • Biocare Pharmaceutica Organogram
  • Company Sales Trend
    • Biocare Pharmaceutica Sales Trend (2005-2023)
  • Achievements
    • Achievements
    • Major Projects
  • Distribution Network
• Products
  • Therapeutic Segment/Divisions
    • Antibiotics
      • Sulzone
      • Tazotex
      • Zithrax
      • Azimik
      • Vancomed
      • Infu-Mox
      • Soletab
      • Merosol
      • Colistim
      • CBA 150
    • Pain Killers
      • Kelac Injection
      • Kelac Tab
    • Antiemetic
      • upcoming
    • Anti-Fungal
      • upcoming
    • Antispasmodic
      • upcoming
    • Gastroenterology/Hepatology
      • Secomep
      • Ceron α
      • Hepamed
    • Nephrology/Immunos-
      uppressive Agents
      • Neocyspin
      • Cycopin
      • Cyonse
    • Anesthetics
      • Flurane
    • Vasoconstrictor
      • Nephsav
    • Nutraceuticals
      • CRANOSE
      • CAL-K
  • Future Product Perspective     
• Business Partners
  • Local Partners
  • International Partners
• Picture Gallery
• CONTACT US